Literature DB >> 1549816

Preoperative computed tomography of the brain in non-small cell bronchogenic carcinoma.

P Kormas1, J R Bradshaw, K Jeyasingham.   

Abstract

BACKGROUND: Computed tomography of the brain is the most accurate diagnostic investigation for detecting intracranial tumours. A prospective study was undertaken to try to maximise the cost effectiveness of computed tomography of the brain in the preoperative evaluation of non-small cell lung cancer.
METHODS: All patients with non-small cell lung cancer who were free of neurological symptoms and were thought to be free of metastases from the results of routine investigations were subjected to computed tomography of the brain in the 12-24 hours immediately before surgery.
RESULTS: Of 158 such patients, five showed positive evidence of metastases, confirmed on craniotomy and excision biopsy; one of these patients was found to have a non-metastatic tumour (false positive). Five patients with a negative scan who underwent lung resection returned within 12 months with neurological defects and positive findings on further computed tomography (false negative). The predominant cell type in patients with positive and false negative scans was adenocarcinoma or adenosquamous carcinoma (7/10); the majority had nodal state N2.
CONCLUSIONS: Computed tomography of the brain should be carried out if mediastinal disease is suspected or confirmed in non-small cell lung cancer before proceeding to surgery.

Entities:  

Mesh:

Year:  1992        PMID: 1549816      PMCID: PMC463584          DOI: 10.1136/thx.47.2.106

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Computed tomography and radionuclide brain scanning: comparison in evaluating metastatic lesions to brain.

Authors:  J O Lusins; Z Chayes; H Nakagawa
Journal:  N Y State J Med       Date:  1980-02

2.  Computed tomography of the brain, chest, and abdomen in the preoperative assessment of non-small cell lung cancer.

Authors:  D Grant; D Edwards; P Goldstraw
Journal:  Thorax       Date:  1988-11       Impact factor: 9.139

3.  Surgical treatment of brain metastases from lung cancer.

Authors:  N Sundaresan; J H Galicich; E J Beattie
Journal:  J Neurosurg       Date:  1983-05       Impact factor: 5.115

Review 4.  Carcinoma of lung with a solitary cerebral metastasis. Surgical management and review of the literature.

Authors:  E Deviri; A Schachner; A Halevy; M Shalit; M J Levy
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

5.  Brain metastases from primary bronchial carcinoma: a statistical study of 741 necropsies.

Authors:  S GALLUZZI; P M PAYNE
Journal:  Br J Cancer       Date:  1956-09       Impact factor: 7.640

  5 in total
  8 in total

Review 1.  Staging for M disease.

Authors:  T L Winton
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

2.  Preoperative screening for metastases in lung cancer.

Authors:  M F Muers
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

3.  Incidence of symptomatic brain metastasis following radical radiotherapy for non-small cell lung cancer: is there a role for prophylactic cranial irradiation?

Authors:  E Khan; S Ismail; R Muirhead
Journal:  Br J Radiol       Date:  2012-09-19       Impact factor: 3.039

4.  [Diagnostic evaluation of lung cancer].

Authors:  F J F Herth; C-P Heussel
Journal:  Internist (Berl)       Date:  2011-02       Impact factor: 0.743

5.  Comparative study of vascular enhancement on post-contrast CT using three dosages of iodinated contrast media for the aim of detecting brain metastasis in patients with lung cancer.

Authors:  Katsumi Hayakawa; Toshiki Shiozaki; Akira Yamamoto; Soichi Kubo; Tsutomu Osako
Journal:  Radiat Med       Date:  2006-02

Review 6.  Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer.

Authors:  T K Hillers; M D Sauve; G H Guyatt
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

7.  Early stage non-small cell lung cancer patients need brain imaging regardless of symptoms.

Authors:  Takahiro Ando; Hidenori Kage; Minako Saito; Yosuke Amano; Yasushi Goto; Jun Nakajima; Takahide Nagase
Journal:  Int J Clin Oncol       Date:  2018-02-26       Impact factor: 3.402

8.  Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer.

Authors:  Garrett T Wasp; Christopher Del Prete; Jonathan A D Farrell; Konstantin H Dragnev; Gregory Russo; Graham T Atkins; Joseph D Phillips; Gabriel A Brooks
Journal:  Heliyon       Date:  2020-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.